Israel’s Teva Pharmaceutical Industries have agreed to acquire Mexican drug maker Rimsa for $2.3 billion, extending the Israel-based drug maker’sContinue Reading
Israel’s Teva Pharmaceutical Industries have agreed to acquire Mexican drug maker Rimsa for $2.3 billion, extending the Israel-based drug maker’s vicinity in Mexico. Teva shares rose 1.9% to $57.55 in late premarket trading. It is Teva’s second real obtaining as of late. In late July it consented to pay $40.5 billion in real money and stock for Allergan’s generics drug business to harden its position as the world’s No. 1 maker of generic drugs. The deal with Rimsa, Teva which has a little vicinity in the nation, will turn into a main pharmaceutical company in Mexico, and the second largest…